» Articles » PMID: 34783057

SARS-CoV-2 Spike Evolutionary Behaviors; Simulation of N501Y Mutation Outcomes in Terms of Immunogenicity and Structural Characteristic

Overview
Journal J Cell Biochem
Date 2021 Nov 16
PMID 34783057
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a large number of mutations in its genome have been reported. Some of the mutations occur in noncoding regions without affecting the pathobiology of the virus, while mutations in coding regions are significant. One of the regions where a mutation can occur, affecting the function of the virus is at the receptor-binding domain (RBD) of the spike protein. RBD interacts with angiotensin-converting enzyme 2 (ACE2) and facilitates the entry of the virus into the host cells. There is a lot of focus on RBD mutations, especially the displacement of N501Y which is observed in the UK/Kent, South Africa, and Brazilian lineages of SARS-CoV-2. Our group utilizes computational biology approaches such as immunoinformatics, protein-protein interaction analysis, molecular dynamics, free energy computation, and tertiary structure analysis to disclose the consequences of N501Y mutation at the molecular level. Surprisingly, we discovered that this mutation reduces the immunogenicity of the spike protein; also, displacement of Asn with Tyr reduces protein compactness and significantly increases the stability of the spike protein and its affinity to ACE2. Moreover, following the N501Y mutation secondary structure and folding of the spike protein changed dramatically.

Citing Articles

Research progress of spike protein mutation of SARS-CoV-2 mutant strain and antibody development.

Huan X, Zhan J, Gao H Front Immunol. 2024; 15:1407149.

PMID: 39624100 PMC: 11609190. DOI: 10.3389/fimmu.2024.1407149.


Salsoline derivatives, genistein, semisynthetic derivative of kojic acid, and naringenin as inhibitors of A42R profilin-like protein of monkeypox virus: studies.

Chebaibi M, Bourhia M, Amrati F, Slighoua M, Mssillou I, Aboul-Soud M Front Chem. 2024; 12:1445606.

PMID: 39318419 PMC: 11420140. DOI: 10.3389/fchem.2024.1445606.


Identification of conserved linear epitopes in the SARS-CoV-2 receptor-binding region using monoclonal antibodies.

Yang Y, Zhou L, Mo C, Hu L, Zhou Z, Fan Y Heliyon. 2023; 9(6):e16847.

PMID: 37292282 PMC: 10238280. DOI: 10.1016/j.heliyon.2023.e16847.


Structural evolution of Delta lineage of SARS-CoV-2.

Gomari M, Tarighi P, Choupani E, Abkhiz S, Mohamadzadeh M, Rostami N Int J Biol Macromol. 2022; 226:1116-1140.

PMID: 36435470 PMC: 9683856. DOI: 10.1016/j.ijbiomac.2022.11.227.


Lethargy and quadraparesis as initial manifestations of covid-19 child: Case report.

Hammed A, Badour M, Baqla S Ann Med Surg (Lond). 2022; 84:104911.

PMID: 36415678 PMC: 9671604. DOI: 10.1016/j.amsu.2022.104911.


References
1.
Kuzmina A, Khalaila Y, Voloshin O, Keren-Naus A, Boehm-Cohen L, Raviv Y . SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera. Cell Host Microbe. 2021; 29(4):522-528.e2. PMC: 7980135. DOI: 10.1016/j.chom.2021.03.008. View

2.
Liu Y, Liu J, Plante K, Plante J, Xie X, Zhang X . The N501Y spike substitution enhances SARS-CoV-2 infection and transmission. Nature. 2021; 602(7896):294-299. PMC: 8900207. DOI: 10.1038/s41586-021-04245-0. View

3.
Hoffmann M, Arora P, Gross R, Seidel A, Hornich B, Hahn A . SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell. 2021; 184(9):2384-2393.e12. PMC: 7980144. DOI: 10.1016/j.cell.2021.03.036. View

4.
Hallen M, Martin J, Ojewole A, Jou J, Lowegard A, Frenkel M . OSPREY 3.0: Open-source protein redesign for you, with powerful new features. J Comput Chem. 2018; 39(30):2494-2507. PMC: 6391056. DOI: 10.1002/jcc.25522. View

5.
Habibi M, Bakhshi P, Aghdam R . LRC: A new algorithm for prediction of conformational B-cell epitopes using statistical approach and clustering method. J Immunol Methods. 2015; 427:51-7. DOI: 10.1016/j.jim.2015.09.006. View